Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5294]

'Research autopsy’ helps scientists study why certain cancer therapies stop working

'Research autopsy’ helps scientists study why certain cancer therapies stop working

Experimental drug development approach points to better targeted therapies for treatment-resistant leukaemia

Experimental drug development approach points to better targeted therapies for treatment-resistant leukaemia

Olapirib in combination with abiraterone delayed disease progression in first line mCRPC

Olapirib in combination with abiraterone delayed disease progression in first line mCRPC

Right program could turn immune cells into cancer killers

Right program could turn immune cells into cancer killers

Scientists find a new way to reverse immune suppression in tumours

Scientists find a new way to reverse immune suppression in tumours

Innovative ovarian cancer research newly supported by R37 MERIT Award

Innovative ovarian cancer research newly supported by R37 MERIT Award

Putting a target on breast cancer that spreads to the brain

Putting a target on breast cancer that spreads to the brain

ESMO 2021: First-line CDK 4/6 inhibition shows overall survival benefit for metastatic breast cancer

ESMO 2021: First-line CDK 4/6 inhibition shows overall survival benefit for metastatic breast cancer

ESMO 2021: Update on INVICTUS trial shows improved overall median survival in GIST patients using ripretinib

ESMO 2021: Update on INVICTUS trial shows improved overall median survival in GIST patients using ripretinib

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20...

More from ecancer